Development and characterization dual responsive magnetic nanocomposites for targeted drug delivery systems
Source abstract
Abstract
A drug delivery system based on dual responsive units was developed. An appealing pH- and thermo-responsive triblock terpolymer as the drug carrier was synthesized by RAFT polymerization of N-isopropyl acrylamide and methacrylic acid monomers using PEG-RAFT agent. The Fe3O4 magnetic nanoparticles were synthesized by co-precipitation of Fe salts. Synthesized samples were characterized by FT-IR, XRD, GPC, SEM and TEM. The dual responsive behaviour and self-assembly of the triblock terpolymers in aqueous solution were investigated using UV–vis transmittance and DLS. Based on the results of DLS and TEM, the average size of micelles was 170, 125 and 30 nm. The triblock terpolymer was used as a chemotherapy drug carrier and doxorubicin as a model drug. The release rate of the drug at two different temperatures (37 °C and 42 °C) and pHs (5.8 and 7.4) was studied. The in vitro cytotoxicity assay of free doxorubicin and drug-loaded magnetic nanoparticles was studied. The MTT assay exhibited that these polymers are biocompatible and no toxicity. As well, IC50 of the DOX-loaded triblock terpolymer in MTT test demonstrated that these systems could be suitable for the treatment of cancer.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Polymer Synthesis and Characterization · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, Payame Noor University, Tehran, Iran;
National Institute For Medical Research Development (Nimad), Tehran, Iran;
Universal Scientific Education and Research Network (USERN), Tabriz, Iran;
Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
References (64)
Show source-provided references
1. 10.1111/j.1476-5381.2010.01089.x10.1111/j.1476-5381.2010.01089.x ↗
2. 10.1126/science.120411710.1126/science.1204117 ↗
3. 10.1007/s12012-007-0023-310.1007/s12012-007-0023-3 ↗
4. 10.1186/1471-2407-14-84210.1186/1471-2407-14-842 ↗
5. 10.1016/S0304-419X(03)00031-310.1016/S0304-419X(03)00031-3 ↗
6. 10.1016/j.addr.2008.03.01810.1016/j.addr.2008.03.018 ↗
7. 10.1007/s12094-012-0766-610.1007/s12094-012-0766-6 ↗
8. 10.1166/jbn.2013.158310.1166/jbn.2013.1583 ↗
9. 10.1039/C2CS35265F10.1039/C2CS35265F ↗
10. 10.1038/nmat379210.1038/nmat3792 ↗
11. 10.1016/j.biomaterials.2014.01.04110.1016/j.biomaterials.2014.01.041 ↗
12. 10.4314/tjpr.v13i7.2310.4314/tjpr.v13i7.23 ↗
13. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
14. 10.1517/17425247.2010.50256010.1517/17425247.2010.502560 ↗
15. 10.1166/jnn.2015.958510.1166/jnn.2015.9585 ↗
16. 10.1007/s13204-013-0216-y10.1007/s13204-013-0216-y ↗
17. Saadatjou N · Pharm Chem J · 2017 · 1
18. 10.7314/APJCP.2014.15.2.51710.7314/APJCP.2014.15.2.517 ↗
19. 10.1016/j.powtec.2012.11.00310.1016/j.powtec.2012.11.003 ↗
20. 10.1016/j.addr.2012.09.02610.1016/j.addr.2012.09.026 ↗
21. 10.1016/j.canlet.2013.04.03210.1016/j.canlet.2013.04.032 ↗
22. 10.1021/mp500710x10.1021/mp500710x ↗
23. 10.1039/C4PY00601A10.1039/C4PY00601A ↗
24. 10.1021/am508291k10.1021/am508291k ↗
25. 10.1039/C6PY01101B10.1039/C6PY01101B ↗
26. 10.1166/sam.2015.216110.1166/sam.2015.2161 ↗
27. 10.1038/nmat377610.1038/nmat3776 ↗
28. 10.1016/j.biomaterials.2012.05.02510.1016/j.biomaterials.2012.05.025 ↗
29. 10.1016/j.biomaterials.2013.01.08410.1016/j.biomaterials.2013.01.084 ↗
30. Gerweck LE · Cancer Res · 1996 · 56 · 1194
31. 10.1021/cm051736410.1021/cm0517364 ↗
32. 10.1016/S0014-3057(00)00220-210.1016/S0014-3057(00)00220-2 ↗
33. 10.1021/ma951390q10.1021/ma951390q ↗
34. 10.1517/17425247.2011.58165610.1517/17425247.2011.581656 ↗
35. 10.1016/S1359-6446(05)03575-010.1016/S1359-6446(05)03575-0 ↗
36. 10.1016/j.biomaterials.2012.08.07210.1016/j.biomaterials.2012.08.072 ↗
37. 10.1007/s00289-011-0557-110.1007/s00289-011-0557-1 ↗
38. 10.1016/j.eurpolymj.2012.12.01610.1016/j.eurpolymj.2012.12.016 ↗
39. 10.1002/1097-0126(200009)49:9<993::AID-PI506>3.0.CO;2-610.1002/1097-0126(200009)49:9<993::AID-PI506>3.0.CO;2-6 ↗
40. 10.1016/j.progpolymsci.2006.11.00310.1016/j.progpolymsci.2006.11.003 ↗
41. 10.1016/j.jcis.2009.02.06810.1016/j.jcis.2009.02.068 ↗
42. 10.1016/j.biopha.2016.06.02610.1016/j.biopha.2016.06.026 ↗
43. 10.1016/j.biopha.2014.12.01210.1016/j.biopha.2014.12.012 ↗
44. 10.5897/AJB09.90410.5897/AJB09.904 ↗
45. 10.1039/b810061f10.1039/b810061f ↗
46. 10.1021/bm050781210.1021/bm0507812 ↗
47. 10.1007/s10965-006-9050-110.1007/s10965-006-9050-1 ↗
48. 10.1021/am501212g10.1021/am501212g ↗
49. 10.1016/S1567-5394(02)00032-410.1016/S1567-5394(02)00032-4 ↗
50. Khalilov RI · Russ Plant Physiol · 1993 · 3 · 338
51. Youssef NA · Int J Pharm Sci Health Care · 2013 · 1 · 1
52. 10.1134/S000635091102014X10.1134/S000635091102014X ↗
53. Khalilov RI · Doklady Akademii Nauk · 1992 · 4 · 850
54. 10.3109/21691401.2016.114673110.3109/21691401.2016.1146731 ↗
55. 10.3109/21691401.2016.114673210.3109/21691401.2016.1146732 ↗
56. 10.3109/21691401.2016.117069610.3109/21691401.2016.1170696 ↗
57. 10.3109/21691401.2016.116770410.3109/21691401.2016.1167704 ↗
58. 10.3109/21691401.2016.115348310.3109/21691401.2016.1153483 ↗
59. 10.1080/21691401.2016.126911710.1080/21691401.2016.1269117 ↗
60. 10.1016/0005-2736(93)90218-O10.1016/0005-2736(93)90218-O ↗
61. 10.1021/la200347u10.1021/la200347u ↗
62. 10.1016/j.jconrel.2007.05.01010.1016/j.jconrel.2007.05.010 ↗
63. Bialik-Wąs K · Acta Biochim Pol · 2013 · 60 · 835
64. 10.1016/j.biomaterials.2016.01.06110.1016/j.biomaterials.2016.01.061 ↗